Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

OnCore Login
Login to Oncore Network

Login to Oncore Network

Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

Froedtert & the Medical College of Wisconsin

9200 W. Wisconsin Avenue, Milwaukee, WI 53226

Research cures cancer, and cancer is the top strategic priority of the Froedtert & the Medical College of Wisconsin. Its mission is to uncover the causes of cancer through scientific research and to translate this knowledge into effective treatment of cancer patients. MCW is dedicated to reducing the cancer burden through innovative research into its causes, prevention, early detection, and treatment. Basic science and translational and clinical research are integrated with patient care and professional and community education, with an emphasis on reaching underserved populations.

The Cancer Center is a network of cancer experts, investigators, clinicians, research programs, equipment facilities, and resources – an overarching organization that connects all cancer-related activities and represents the collective cancer effort at the Medical College of Wisconsin.

Website: Froedtert & the Medical College of Wisconsin

Contact:
Michelle Price or Lisa Croatt
414-805-3666

Trials at this location:

HCRN-GI18-333

Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and gastroesophageaL junction (GEJ) adenocarcinoma (SEQUEL)

Status: Open to Accrual
Read More

HCRN-GU18-343

A Phase 2 Study of CAbozantinib in Combination With AtezolizumaB as NeoAdjuvant Treatment for Muscle-Invasive BladdEr Cancer (ABATE)

Status: Open to Accrual
Read More

HCRN-GU19-385

Phase II Trial of Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer (PLANE-PC)

Status: Open to Accrual
Read More

HCRN-BRE18-334

A Phase II circulating tumor DNA enriched, genomically directed post-neoadjuvant trial for patients with residual triple negative breast cancer (PERSEVERE)

Status: Closed to Accrual
Read More